BSE filing, BSE: 540782. Summary written from the filing by ALFA Finder's alert engine.
Sanghvi Brands Ltd: key numbers
- Share price
- ₹12.90
- Market cap
- ₹13.44 Cr
- Revenue (annual)
- ₹14.61 Cr
- Net profit (annual)
- ₹1.58 Cr
- P/E (TTM)
- 8.5×Sector 43.4×
- Promoter holding
- 53.61%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanghvi Brands Ltd
All →Sanghvi Brands Board Meeting Date
Sanghvi Brands Limited has scheduled a board meeting on November 3, 2026, to consider and approve its unaudited financial results and issue proceeds utilization statement.
Sanghvi Brands Other Announcement
Sanghvi Brands Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b) of the SEBI Listing Regulations.
Sanghvi Brands Management Change
Sanghvi Brands Limited appointed Rohit Prakash Bafana as Non-Executive Independent Director and M/s. Komandoor & Co. LLP as Statutory Auditor, each for a 60-month term.
Sanghvi Brands Annual General Meeting
Sanghvi Brands Ltd held its 16th Annual General Meeting on September 18, 2026. Members approved financial statements and the appointment of new directors and auditors.
Sanghvi Brands Annual General Meeting
Sanghvi Brands Limited announced the closure of its Register of Members and Share Transfer Books for the 16th Annual General Meeting scheduled for September 18, 2026.
Sanghvi Brands Price Movement Clarification
Sanghvi Brands responded to an exchange query regarding price/volume movement. The company confirmed it has no undisclosed material information affecting its share price or volume.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.